THE EFFECT OF SURGICAL PREPARATION AND IN-VITRO DISTENSION ON THE INTRINSIC FIBRINOLYTIC-ACTIVITY OF HUMAN SAPHENOUS-VEIN

被引：15

作者：

UNDERWOOD, MJ

MORE, R

WEERESENA, N

FIRMIN, RK

DEBONO, DP

机构：

[1] The University, Department of Cardiology, Glenfield General Hospital, Leicester

[2] The Department of Cardiothoracic Surgery, Groby Road Hospital, Leicester

来源：

EUROPEAN JOURNAL OF VASCULAR SURGERY | 1993年 / 7卷 / 05期

关键词：

FIBRINOLYTIC ACTIVITY; DISTENSION; SAPHENOUS VEIN;

D O I：

10.1016/S0950-821X(05)80363-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The objective of this study was to assess the effect of distension on the intrinsic fibrinolytic activity of human saphenous vein during its preparation for use as a bypass conduit prior to coronary artery surgery. Fibrinolytic activity was studied using fibrin plate techniques and Chromogenic assays for extractable tPA and uPA. Samples were obtained from patients undergoing routine coronary surgery. Fibrinolytic activity was compared in control vein (untouched) vein that had been prepared for use as a bypass conduit (surgical dissection, ligation of side branches and careful but uncontrolled manual distension) and segments of dissected vein distended in vitro to pressures of 230 or 120 mmHg. Uncontrolled distension and distension to 230 mmHg impaired fibrinolytic activity as determined by areas of lysis on fibrin plates (p < 0.05), (p < 0.005), tPA activity (p < 0.005) (p < 0.005) and tPA activity (p < 0.05), (p < 0.005). Distension to 120 mmHg had no effect on the fibrinolytic activity of human saphenous vein. Impaired fibrinolytic activity caused by uncontrolled distension of saphenous vein prior to its use as a vascular conduit may contribute to early vein graft thrombosis and can be avoided using controlled distension to <120 mmHg. © 1993 Grune & Stratton Ltd.

引用

页码：518 / 522

页数：5

共 26 条

[1]

Lefrac, The internal mammary artery bypass graft: Praise versus practice, Tex Heart Inst J, 14, pp. 139-143, (1987)

[2]

Kirklin, Et al., Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and theraputic cardiovascular procedures (subcommittee on coronary artery bypass graft surgery), J Am Coll Cardiol, 17, pp. 543-589, (1991)

[3]

Fuchs, Mitchener, Hagen, Postoperative changes in autologous vein grafts, Ann Surg, 188, pp. 1-15, (1978)

[4]

Unni, Kottke, Titus, Et al., Pathological changes in aorto-coronary saphenous vein grafts, Am J Cardiol, 34, pp. 526-532, (1974)

[5]

Angelini, Brekenridge, Psaila, Et al., Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin, Cardiovascular Research, 21, pp. 28-33, (1985)

[6]

Todd, Histological localisation of plasminogen activator, J Pathol Bacteriol, 78, pp. 281-287, (1959)

[7]

Astrup, The biological significance of fibrinolysis, Lancet, 2, pp. 565-569, (1956)

[8]

Levin, Loskutoff, Cultured bovine aortic endothelial cells produce both urokinase and tissue-type plasminogen activators, J Cell Biol, 94, pp. 631-636, (1982)

[9]

Gottlob, The preservation of venous endothelium by dissection without touching and by an atraumatic technique of vascular anastomosis, Min Chirur, 32, pp. 693-700, (1977)

[10]

Angelini, Passani, Breckenridge, Newby, Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts, Cardiovasc Res, 21, pp. 902-907, (1987)

← 1 2 3 →